News for Eloxx Pharmaceuticals, Inc. (ELOX)

Eloxx Pharmaceuticals Provides Pipeline and Financing Updates

ELX-02 Granted Orphan Drug Designation (ODD) from U.S. Food and Drug Administration (FDA) for Treatment of Alport Syndrome Pre-Investigational New Drug...

Proposed Changes to BenevolentAI's Board Composition

NEW YORK,, March 20, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of Latch, Inc....

Eloxx Pharmaceuticals (ELOX) has priced a public offering to raise $2 million, the company said Tuesday

Highly regarded renal pathologist and transmission electron microscopy (TEM) expert independently confirms previously reported qualitative assessment by...

Investigational New Drug (IND) application submitted to U.S. Food and Drug Administration (FDA) for ELX-02 for the treatment of Alport syndrome with...

Given below is a list of some of the stocks making big moves in Wednesday's pre-market trading (as of 07.55 A.M. ET)..

Announced today that all 3 patients (100% response rate) treated with ELX-02 showed an improvement in podocyte foot process effacement post-treatment in...

Eloxx Pharmaceuticals Inc. (ELOX) on Thursday said it has been granted extension by Nasdaq to regain compliance with the listing rule.The listing rule requires a listed company to have...

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.35 A.M. ET)..

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.35 A.M. ET)..

SEATTLE, June 01, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14%

The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.40 A.M. ET)..

The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.40 A.M. ET)..

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.

The Cystic Fibrosis (CF) therapeutic development pipeline contains candidate drugs that address many different aspects of the disease. Drug development for...